Department of Neurosurgery, Tel Aviv Sourasky Medical Center, Tel Aviv University, Israel.
AJNR Am J Neuroradiol. 2010 May;31(5):947-54. doi: 10.3174/ajnr.A1959. Epub 2010 Feb 25.
Endovascular embolization with Onyx is one of the tools used in the treatment of intracerebral AVMs. The recent introduction of a new microcatheter with detachable tip has led us to adopt a new treatment approach by using endovascular embolization with Onyx as the main treatment for brain AVM with curative intent. The purpose of the present study is to evaluate our initial results by using this new treatment strategy with special emphasis on the safety and feasibility of the technique.
Forty-three consecutive patients were treated by embolization for brain AVM over a 14-month period, mostly by using Onyx and a microcatheter with detachable tip. Twenty-six of these patients (60%) harbored Spetzler-Martin AVMs of grades 4-5.
Endovascular treatments were completed in 29 out of 43 patients; the median number of procedures per patient was 2 (range, 1-4). Complete obliteration by using embolization exclusively was achieved in 16 patients, resulting in a 55% cure rate in patients who concluded treatments (16/29) and 37% in the cohort (16/43). The amount of Onyx injected by using microcatheters with detachable tips was significantly larger than that injected with the nondetachable microcatheters (mean volume, 2.5 +/- 2.2 versus 1.7 +/- 1.3 mL, respectively, P < .05, t test). Seven clinical complications were observed in a total of 76 embolization sessions (9.2%).
Endovascular embolization of brain AVM by using Onyx and SONIC results in a relatively high complete obliteration. The use of the microcatheter with detachable tip adds several advantages, mainly in that higher volumes of Onyx can be safely injected.
血管内栓塞治疗颅内动静脉畸形(AVM)是一种治疗方法。最近引入了一种新型的可解脱尖端微导管,使我们能够采用一种新的治疗方法,即使用血管内栓塞 Onyx 作为有治疗意图的脑 AVM 的主要治疗方法。本研究的目的是通过使用这种新的治疗策略来评估我们的初步结果,特别强调该技术的安全性和可行性。
在 14 个月的时间里,我们使用血管内栓塞治疗了 43 例脑 AVM 患者,其中大多数患者使用 Onyx 和可解脱尖端微导管进行治疗。这些患者中有 26 例(60%)患有 Spetzler-Martin 分级 4-5 的 AVM。
43 例患者中有 29 例完成了血管内治疗;每位患者的中位数治疗次数为 2 次(范围,1-4 次)。16 例患者通过单纯栓塞实现了完全闭塞,因此在完成治疗的 29 例患者中(16/29),有 55%的患者达到了治愈,在所有患者中(16/43),有 37%的患者达到了治愈。使用可解脱尖端微导管注射的 Onyx 量明显大于使用不可解脱微导管注射的 Onyx 量(平均体积分别为 2.5±2.2 毫升和 1.7±1.3 毫升,P<.05,t 检验)。在总共 76 次栓塞治疗中观察到 7 例临床并发症(9.2%)。
使用 Onyx 和 SONIC 进行脑 AVM 的血管内栓塞治疗可实现较高的完全闭塞率。使用可解脱尖端微导管具有几个优点,主要是可以更安全地注射更大体积的 Onyx。